US EditionPfizer agrees to lower prescription drug costs for Medicaid in a deal with Trump
Pfizer will match the lowest drug prices in developed countries for Medicaid and invest $70 billion in U.S. manufacturing, supporting efforts to lower U.S. drug costs, officials said.
- Pfizer has agreed to lower prescription drug costs for Medicaid under a deal with the Trump administration, announced by President Donald Trump.
- The deal includes most-favored-nation pricing for Medicaid and a commitment from Pfizer to spend $70 billion on domestic manufacturing.
- Patients are expected to see lower prices as part of this agreement, starting in 2026, benefiting those without insurance or those negotiating for better deals.
- Trump emphasized that this is a significant step in reversing high drug prices in the U.S., which he claims are often three times higher than in other developed nations.
464 Articles
464 Articles
Can TrumpRx really lower drug prices?
Call him the Pharmacist-in-Chief. President Donald Trump last week announced the launch of TrumpRx, a website where Americans will be able to find discounted medicine. It is part of a “sweeping deal” with Pfizer to offer lower-priced drugs to the public.The pharmaceutical company will highlight many of its brand-name drugs at a 50% discount on the new website, said CNN. (The site will not “sell or distribute medications” but instead let users fi…
Los Angeles Times
Independent Español“I can’t tell you how big this is,” the president said.
Trump Announces Pfizer Deal Offering Discounts On Medicines Via 'TrumpRx' Website
Pfizer has agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump administration, President Donald Trump said Tuesday as he promised similar deals with other drugmakers under the threat of tariffs.
Under pressure from Donald Trump, Pfizer cuts prices on some drugs in the US
Yielding to demands from Washington, the pharmaceutical company has agreed to lower the price of medications available under public health insurance program Medicaid in exchange for a three-year exemption from tariffs.
Why Pfizer Stock Trounced the Market Today @themotleyfool #stocks $PFE
Key PointsInvestors continued to be positive on the pharmaceutical giant following a deal reached with the government.Among other benefits, it will have a reprieve from potential tariffs on its industry.10 stocks we like better than Pfizer › Still basking in the glow of a likely advantageous deal it signed with the government the previous day, Pfizer's (NYSE: PFE) stock was extremely healthy on Hump Day. That positive sentiment was boosted by a …
Coverage Details
Bias Distribution
- 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
